DCGI approves DRDO-developed anti-Covid oral drug, could reduce supplemental oxygen dependence

  • Staff Reporter

DCGI approves DRDO-developed anti-Covid oral drug, could reduce supplemental oxygen dependence

Popular Videos
    More videos